Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.58%199.99M | 122.28%193.61M | -61.91%450.74M | -81.38%49.82M | -56.19%127.92M | -35.37%185.91M | -74.10%87.1M | -5.54%1.18B | -16.02%267.56M | -3.37%291.98M |
Cost of revenue | 247.55%333.58M | -4.00%97.58M | -8.07%431.36M | -7.69%115.74M | -4.37%117.98M | -12.90%95.98M | -7.84%101.66M | -1.83%469.26M | -0.70%125.38M | 8.42%123.37M |
Gross profit | -248.56%-133.59M | 759.69%96.02M | -97.29%19.38M | -146.37%-65.93M | -94.11%9.94M | -49.32%89.92M | -106.44%-14.56M | -7.83%714.22M | -26.07%142.18M | -10.50%168.6M |
Operating expense | -7.99%140.06M | -17.84%146.22M | 17.71%642M | 20.37%157.41M | 12.14%154.4M | 9.71%152.22M | 28.79%177.97M | -0.46%545.39M | -5.40%130.77M | 1.71%137.69M |
Operating profit | -339.25%-273.65M | 73.93%-50.19M | -468.80%-622.62M | -2,056.66%-223.33M | -567.32%-144.47M | -261.03%-62.3M | -319.25%-192.52M | -25.62%168.82M | -78.89%11.41M | -41.67%30.91M |
Net non-operating interest income (expenses) | 178.85%287K | 90.48%-6K | -102.98%-1.05M | -100.79%-280K | -1,988.89%-340K | -477.78%-364K | -117.24%-63K | 4,434.28%35.15M | 36,792.71%35.23M | 106.14%18K |
Non-operating interest income | 17.99%328K | -22.71%211K | -97.19%1.02M | -99.31%243K | -20.07%227K | 17.30%278K | -6.51%273K | 2,037.48%36.27M | 11,680.73%35.46M | -9.27%284K |
Non-operating interest expense | -93.61%41K | -35.42%217K | 84.31%2.07M | 122.55%523K | 113.16%567K | 114.00%642K | 4.67%336K | -55.26%1.12M | -40.81%235K | -56.11%266K |
Net investment income | 207.56%185K | -145.16%-126K | -26K | 33K | -418.75%-166K | 8.51%-172K | 834.21%279K | 41.82%-32K | ||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 959.29%31.77M | -98.11%33K | 21.29%-2.11B | 63.44%-992.15M | -773,776.55%-1.12B | 198.11%3M | -94.70%1.75M | -649.76%-2.68B | -658.22%-2.71B | 145K |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -114.26%-713K | -92.92%488K | 693.12%1.14B | 61.59%-73.79M | 1.2B | 3,084.71%5M | 6.89M | -103.94%-191.96M | -192.12M | 0 |
Less:Other special charges | ---- | ---- | -4,287.26%-6.89M | --0 | --0 | --0 | ---6.89M | 100.00%-157K | --0 | --0 |
Less:Write off | --713K | ---488K | -689.05%-1.13B | --73.79M | ---1.2B | ---- | ---- | --192.12M | ---- | ---- |
Other non-operating income (expenses) | -63.38%1.41M | 34.56%292K | 182.75%7M | 147.80%2.03M | 191.51%895K | 13,882.14%3.86M | 106.77%217K | 48.09%-8.46M | 22.91%-4.25M | -175.23%-978K |
Income before tax | -372.17%-240.71M | 73.01%-49.51M | 40.68%-1.59B | 55.03%-1.29B | -317.65%-65.44M | -228.83%-50.98M | -256.06%-183.45M | -150.09%-2.68B | -825.37%-2.86B | -99.38%30.07M |
Income tax | -15,280.00%-159.39M | -10.00%945K | -95.53%3.78M | -98.84%945K | -30.00%735K | 0.00%1.05M | -17.52%1.05M | -94.51%84.58M | 192.40%81.21M | -99.94%1.05M |
Net income | -56.29%-81.32M | 72.65%-50.46M | 42.36%-1.59B | 56.24%-1.29B | -328.05%-66.18M | -235.07%-52.03M | -258.67%-184.5M | -172.62%-2.76B | -1,229.13%-2.94B | -99.10%29.02M |
Net income continuous operations | -56.29%-81.32M | 72.65%-50.46M | 42.36%-1.59B | 56.24%-1.29B | -328.06%-66.18M | -235.07%-52.03M | -258.67%-184.5M | -172.62%-2.76B | -1,229.12%-2.94B | -99.10%29.02M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -56.29%-81.32M | 72.65%-50.46M | 42.36%-1.59B | 56.24%-1.29B | -328.05%-66.18M | -235.07%-52.03M | -258.67%-184.5M | -172.62%-2.76B | -1,229.13%-2.94B | -99.10%29.02M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -56.29%-81.32M | 72.65%-50.46M | 42.36%-1.59B | 56.24%-1.29B | -328.05%-66.18M | -235.07%-52.03M | -258.67%-184.5M | -172.62%-2.76B | -1,229.13%-2.94B | -99.10%29.02M |
Gross dividend payment | ||||||||||
Basic earnings per share | -55.26%-1.77 | 72.64%-1.1 | 42.47%-34.72 | 56.32%-28.12 | -325.00%-1.44 | -235.71%-1.14 | -258.27%-4.02 | -172.53%-60.35 | -1,227.22%-64.37 | -99.10%0.64 |
Diluted earnings per share | -55.69%-1.7748 | 72.64%-1.1 | 42.47%-34.72 | 56.31%-28.1217 | -328.05%-1.4443 | -235.71%-1.14 | -258.89%-4.02 | -172.71%-60.35 | -1,227.22%-64.37 | -99.10%0.6334 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%3 | 0.00%3 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |